With offices in Seattle, Wash., and Irvine, Calif., Visus Therapeutics is a clinical-stage pharmaceutical company focused on developing innovative ophthalmic therapies to improve vision for people around the world. The company is developing novel miotic formulations for a once-daily eye drop to correct the loss of near vision associated with presbyopia. In parallel, Visus Therapeutics is focused on advancing its pipeline of early-stage ophthalmic product candidates with applications in ocular surface disease, glaucoma and age-related macular degeneration. Additionally, Visus Therapeutics has entered into a worldwide exclusive licensing agreement with DelSiTech Ltd, a leader in advanced, biodegradable, silica-based, controlled-release materials, to develop novel drug delivery technology that can help optimize the clinical benefit of ophthalmic therapies.
Location: United States, Washington, Seattle
Member count: 11-50
Total raised: $20M
Founded date: 2019
Investors 1
| Date | Name | Website |
| 18.04.2022 | Life Scien... | lspvc.com |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 12.08.2021 | - | $20M | Life Scien... | venturebea... |
Mentions in press and media 5
| Date | Title | Description | Category | Author | Source |
| 12.08.2021 | Visus Ther... | Visus Therapeutics, a Seattle-... | - | Taylor Sop... | geekwire.c... |
| 11.08.2021 | Visus Ther... | Visus Therapeutics, Inc., a Se... | USA | - | finsmes.co... |
| 10.08.2021 | Visus Ther... | Proceeds will support clinical... | - | Business W... | venturebea... |
| 10.03.2021 | Visus Ther... | Visus Therapeutics, a Seattle-... | - | Taylor Sop... | geekwire.c... |
| 09.03.2021 | Visus Ther... | Visus Therapeutics Inc., a Sea... | USA | - | finsmes.co... |